Taiwan's FDA orders recall of ADHD medicine Methydur

Taiwan's Food and Drug Administration (FDA) has ordered the recall of a batch of Methydur Sustained Release Capsules 44mg, a medicine used to treat ADHD, after it failed a dissolution test.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)